• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Core Laboratories Inc. filed SEC Form 8-K: Leadership Update

    3/25/24 4:38:09 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy
    Get the next $CLB alert in real time by email
    8-K
    false00-0000000000195808600019580862024-03-212024-03-21

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): March 21, 2024

    CORE LABORATORIES INC.

    (Exact name of registrant as specified in its charter)

    Delaware

    001-41695

    Not Applicable

    (State or Other Jurisdiction

    of Incorporation)

    (Commission File Number)

    (IRS Employer

    Identification No.)

     

     

     

    6316 Windfern Road

    Houston, TX

    77040

    (Address of Principal Executive Offices)

    (Zip Code)

    Registrant’s Telephone Number, Including Area Code: (713) 328-2673

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange on which registered

    Common Stock (par value $0.01)

     

    CLB

     

    New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


     

     

     

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On March 21, 2024, Mr. Kevin Daniels announced his intention to resign as Vice President and Chief Accounting Officer of Core Laboratories Inc. (the “Company”) to pursue other opportunities. Mr. Daniels departure is not the result of any dispute or disagreement with the Company on any matter associated with the Company’s accounting practices or financial statements.

    Effective March 21, 2024, the Board approved the appointment of Mr. Sow Hang Teo to serve as the Company’s Vice President and Chief Accounting Officer. Mr. Teo, age 54, previously served as the Company’s Corporate Controller of Financial Reporting, a position he has held since September 2017. Since joining the Company in February 2006, Mr. Teo has held various positions, including Asia Pacific Shared Service Center Controller, Corporate Group Controller, and Director of Business Processes & Special Projects. Prior to joining the Company, he worked at DNV Asia Pacific from January 1999 to January 2006 as Business Support Manager and Asia Pacific Financial Controller. Mr. Teo began his career in public accounting, working at various firms from July 1994 to December 1998, with the last three years at KPMG in Malaysia. Mr. Teo is a Certified Public Accountant with the Malaysia Institute of Certified Public Accountants and a Chartered Accountant with the Malaysia Institute of Accountants. Mr. Teo completed his undergraduate professional accountancy degree in 1994 from Malaysia and received his MBA from Atlantic International University in 2003. There are no transactions between the Company and Mr. Teo that would require disclosure under Item 404(a) of Regulation S-K.

     

     

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

     

     

     

     

     

     

     

    Core Laboratories Inc.

     

     

     

     

     

     

     

    Dated: March 25, 2024

     

    By

     

    /s/ Christopher S. Hill

     

     

     

     

     

     

    Christopher S. Hill

     

     

     

     

     

     

    Chief Financial Officer

     

     

     

     


    Get the next $CLB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLB

    DatePrice TargetRatingAnalyst
    3/12/2025$15.00 → $16.00Sell → Neutral
    Citigroup
    6/30/2023$22.00 → $21.00Neutral → Sell
    Citigroup
    4/18/2023$21.50Neutral → Underperform
    BofA Securities
    1/9/2023Underperform → Neutral
    BofA Securities
    10/7/2022$24.00 → $17.00Sell → Neutral
    Citigroup
    9/26/2022$20.00Equal-Weight → Underweight
    Morgan Stanley
    4/18/2022$19.50 → $21.30Neutral → Underweight
    Piper Sandler
    1/18/2022$32.00 → $30.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $CLB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

    FOURTH QUARTER REVENUE OF $138.3 MILLION, UP 3% SEQUENTIALLY AND UP 7% YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $15.8 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEARFOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF OVER 11%, DOWN 100 BASIS POINTS SEQUENTIALLY AND 80 BASIS POINTS YEAR-OVER-YEARFOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.21, DOWN 4% SEQUENTIALLY AND YEAR-OVER-YEARFOURTH QUARTER FREE CASH FLOW OF $5.1 MILLIONNET DEBT REDUCED BY $1.2 MILLION; LEVERAGE RATIO IMPROVED TO 1.09COMPANY REPURCHASED 363,207 SHARES OF COMMON STOCK, FOR $5.7 MILLION AGGREGATE PURCHASE PRICECOMPANY ANNOUNCES Q1 2026 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $526.5 MILLI

    2/4/26 5:15:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

    HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on February 4, 2026, and may be accessed through the Company's website at www.corelab.com/investors. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webc

    1/5/26 4:05:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    CORE LAB REPORTS THIRD QUARTER 2025 RESULTS

    REVENUE OF $134.5 MILLION, UP OVER 3% SEQUENTIALLY AND FLAT YEAR-OVER-YEAROPERATING INCOME OF $20.9 MILLION; EX-ITEMS, $16.6 MILLION, UP OVER 14% SEQUENTIALLY AND DOWN 9% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF OVER 12%, EXPANDED 120 BASIS POINTS SEQUENTIALLY, WITH INCREMENTAL MARGINS, EX-ITEMS, OF 48%GAAP EPS OF $0.30; EX-ITEMS, $0.22, UP 16% SEQUENTIALLY, AND DOWN 12% YEAR-OVER-YEARCOMPANY REPURCHASED 462,248 SHARES OF COMMON STOCK, A VALUE OF $5.0 MILLION FREE CASH FLOW OF $6.5 MILLIONNET DEBT REDUCED BY $3.4 MILLION; LEVERAGE RATIO IMPROVED TO 1.10 COMPANY ANNOUNCES Q3 2025 QUARTERLY DIVIDEND HOUSTON, Oct. 22, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core

    10/22/25 5:00:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    $CLB
    SEC Filings

    View All

    Core Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Core Laboratories Inc. /DE/ (0001958086) (Filer)

    2/4/26 4:58:29 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SCHEDULE 13G/A filed by Core Laboratories Inc.

    SCHEDULE 13G/A - Core Laboratories Inc. /DE/ (0001958086) (Subject)

    11/14/25 3:42:50 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SCHEDULE 13G/A filed by Core Laboratories Inc.

    SCHEDULE 13G/A - Core Laboratories Inc. /DE/ (0001958086) (Subject)

    11/14/25 11:18:40 AM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    $CLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 14,310 shares and converted options into 24,952 shares (SEC Form 4)

    4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

    1/5/26 3:18:37 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    SVP Gresham Gwendolyn covered exercise/tax liability with 19,301 shares and converted options into 24,952 shares (SEC Form 4)

    4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

    1/5/26 3:18:06 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    SVP & CFO Hill Christopher Scott covered exercise/tax liability with 32,152 shares and converted options into 61,417 shares (SEC Form 4)

    4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

    1/5/26 3:17:09 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    $CLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Core Labs upgraded by Citigroup with a new price target

    Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously

    3/12/25 7:22:24 AM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    Core Labs downgraded by Citigroup with a new price target

    Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously

    6/30/23 7:19:53 AM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    Core Labs downgraded by BofA Securities with a new price target

    BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50

    4/18/23 9:05:50 AM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    $CLB
    Financials

    Live finance-specific insights

    View All

    CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

    FOURTH QUARTER REVENUE OF $138.3 MILLION, UP 3% SEQUENTIALLY AND UP 7% YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $15.8 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEARFOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF OVER 11%, DOWN 100 BASIS POINTS SEQUENTIALLY AND 80 BASIS POINTS YEAR-OVER-YEARFOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.21, DOWN 4% SEQUENTIALLY AND YEAR-OVER-YEARFOURTH QUARTER FREE CASH FLOW OF $5.1 MILLIONNET DEBT REDUCED BY $1.2 MILLION; LEVERAGE RATIO IMPROVED TO 1.09COMPANY REPURCHASED 363,207 SHARES OF COMMON STOCK, FOR $5.7 MILLION AGGREGATE PURCHASE PRICECOMPANY ANNOUNCES Q1 2026 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $526.5 MILLI

    2/4/26 5:15:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

    HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on February 4, 2026, and may be accessed through the Company's website at www.corelab.com/investors. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webc

    1/5/26 4:05:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    CORE LAB REPORTS THIRD QUARTER 2025 RESULTS

    REVENUE OF $134.5 MILLION, UP OVER 3% SEQUENTIALLY AND FLAT YEAR-OVER-YEAROPERATING INCOME OF $20.9 MILLION; EX-ITEMS, $16.6 MILLION, UP OVER 14% SEQUENTIALLY AND DOWN 9% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF OVER 12%, EXPANDED 120 BASIS POINTS SEQUENTIALLY, WITH INCREMENTAL MARGINS, EX-ITEMS, OF 48%GAAP EPS OF $0.30; EX-ITEMS, $0.22, UP 16% SEQUENTIALLY, AND DOWN 12% YEAR-OVER-YEARCOMPANY REPURCHASED 462,248 SHARES OF COMMON STOCK, A VALUE OF $5.0 MILLION FREE CASH FLOW OF $6.5 MILLIONNET DEBT REDUCED BY $3.4 MILLION; LEVERAGE RATIO IMPROVED TO 1.10 COMPANY ANNOUNCES Q3 2025 QUARTERLY DIVIDEND HOUSTON, Oct. 22, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core

    10/22/25 5:00:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    $CLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Core Laboratories Inc. (Amendment)

    SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

    6/12/23 4:02:30 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

    SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

    2/14/23 4:08:12 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy

    SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

    SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

    2/14/23 9:10:51 AM ET
    $CLB
    Oilfield Services/Equipment
    Energy